Top Tweets for #JoinCARE
Long-term science is built
by people who are willing to wait
when there’s nothing exciting to post.
#JoinCare
Early research isn’t about quick wins.
It’s about staying long enough to understand what fails — and why.
#LongTermScience #JoinCare
Not rushing results doesn’t mean not evaluating.
The difference is what gets evaluated.
We ask whether the question still holds —
not whether the data looks impressive yet.
#JoinCare #ResearchProcess #DeSci
A lot of research gets rushed toward “milestones,”
not because science needs them,
but because systems do.
JoinCare doesn’t optimize for cosmetic progress.
Some stages aren’t meant to look successful —
and forcing them to only distorts the signal.
#JoinCare #ScientificProcess
Slow decisions don’t mean lack of judgment.
Often it’s early judgment that makes things move fast —and fall apart later.
#JoinCare
In JoinCare-backed research,
“not doing it yet”
is often a deliberate decision.Once you push a direction forward,
you’re responsible for carrying it through.
#JoinCare
JoinCare isn’t an accelerator,
and it’s not a https://t.co/bg1ZZa3F88’s closer to being
the space that lets you think things through.
#JoinCare
A lot of decisions that look “slow”
are really about paying upfront
to avoid expensive rewrites later.Not every system is built to afford that.
#JoinCare
After working on antibodies for a while,
you realize the hard question isn’t
“does it work?”It’s whether the effect actually belongs to the target.
#JoinCare #AntibodyResearch
The key advance wasn’t a stronger drug.
It was fixing P2X1
in its native functional conformation.
Using nanodisc technology,
the team stabilized the channel exactly as it behaves in cells.
Only then did meaningful antibodies become possible.
#JoinCare #ScientificMethod #AntibodyPlatform
In many diseases,
the most important targets aren’t undiscovered —
they’re just hard to validate and slow to de-risk.
That’s why membrane proteins and ion channels
have always been high-value, high-barrier targets.
#JoinCare #BioTech #DrugDiscovery
In antibody research, ideas aren’t scarce.
Tolerance for uncertainty is.
When systems only reward what looks safe,
exploration quietly shrinks.
Research design is part of the science itself.
#JoinCare #ResearchEcosystem #BioTech
JoinCare doesn’t pick antibody targets.
It doesn’t judge which approach is “right.”
What it does is simpler:
it helps certain lines of research stay alive
before certainty exists.
#JoinCare #ResearchInfrastructure #DeSci
In antibody research,
the hardest part is often not the idea,
but whether the work can continue through uncertainty.
That’s the stage JoinCare steps into.
#JoinCare #AntibodyResearch #Biotech
Last Seen Hashtags on Sotwe
ometv
Seen from Chile
nolimit #nolimit #nolimit #nolimit #nolimit #nolimit #nolimit #nolimit #nolimit #nolimit #nolimit #nolimit #nolimit #nolimit #nolimit #nolimit #nolimit #nolimit
balikesirmerkez
Seen from Turkey
kızlıkbozma
Seen from Turkey
momson() nolimit()* filter:native_video
Seen from United States
微密圈
snapchatleak video
Seen from Austria
Teenage video.
Seen from Jordan
ruinedorgasm
Seen from Indonesia
كحاب
Most Popular Users
Elon Musk 
@elonmusk
240.7M followers
Barack Obama
@barackobama
119.2M followers
Donald J. Trump
@realdonaldtrump
111.7M followers
Cristiano Ronaldo
@cristiano
111M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
97.7M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
91M followers
KATY PERRY
@katyperry
87.8M followers
Taylor Swift
@taylorswift13
81.7M followers
Lady Gaga
@ladygaga
73.2M followers
Virat Kohli
@imvkohli
70.2M followers
Kim Kardashian
@kimkardashian
69.9M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
64M followers
Neymar Jr
@neymarjr
63M followers
The Ellen Show
@theellenshow
62.4M followers
CNN
@cnn
61.9M followers
Selena Gomez
@selenagomez
60.9M followers
X
@x
60.8M followers